SCHEMBL3612431

SCHEMBL3612431

Cn1nnnc1-c1cc(C(=O)O)sc1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 5/20 0.38
DAO P14920 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 2/20 0.38
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
BCAT2 O15382 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
HCAR2 Q8TDS4 1/20 0.33
MAPK14 Q16539 1/20 0.33
KMO O15229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3603100 0.89 NPC1 (0.40) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3603097 0.82 NPC1 (0.41) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3613039 0.78 KDM4E (0.43) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3609536 0.78 OPRD1 (0.54) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3603091 0.77 PTPN1 (0.45) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3602177 0.77 MAPK14 (0.57) HIF1ANPSR1RXFP1ALDH1A1ABCC9
SCHEMBL3596790 0.75 MAPT (0.44) SMN1; SMN2HIF1ANPSR1KDM4EALDH1A1
SCHEMBL3615683 0.75 KDM4E (0.44) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3601335 0.74 CSNK1D (0.47) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E
SCHEMBL3604637 0.74 HTR2C (0.47) SMN1; SMN2HIF1ANPSR1RXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835476-B2 Synthesis of novel antimicrobials WU FAN (CA) 2014-09-16 US disclosed
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials WU FAN 2010-03-25 US disclosed
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UNIBIOSCREEN SA (BE) 2010-03-25 US disclosed
WO-2006092059-A1 DESIGN AND SYNTHESIS OF NOVEL ANTIMICROBIALS WU FAN (CA) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076028-A1 Design and Synthesis of Novel Antimicrobials MLX, LPXN, TPX2 SMN1; SMN2 4868/4885HIF1A 4467/4885NPSR1 169/4885
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES MIF, IMPDH1, IMPDH2 SMN1; SMN2 714/4885HIF1A 4068/4885NPSR1 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.